{
	"@context": {
		"rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
		"dct": "http://purl.org/dc/terms/",
		"owl": "http://www.w3.org/2002/07/owl#",
		"xsd": "http://www.w3.org/2001/XMLSchema#",
		"rdfs": "http://www.w3.org/2000/01/rdf-schema#",
		"@vocab": "http://ld.nice.org.uk/ns/bnf#",
		"bnf": "http://ld.nice.org.uk/ns/bnf/",
		"nicebnf": "http://ld.nice.org.uk/ns/bnf#",
		"route": "http://ld.nice.org.uk/ns/bnf/Route#",
		"patientGroup": "http://ld.nice.org.uk/ns/bnf/PatientGroup#",
		"indication": "http://ld.nice.org.uk/ns/bnf/Indication#",
		"sideEffect": "http://ld.nice.org.uk/ns/bnf/SideEffect#",
		"classification": "http://ld.nice.org.uk/ns/bnf/Classification#",
		"isLinkedFrom": {
			"@container": "@set"
		},
		"hasInteraction": {
			"@container": "@set"
		},
		"hasMessage": {
			"@container": "@set"
		},
		"hasInteractionList": {
			"@container": "@set"
		},
		"isInteractionListOf": {
			"@container": "@set"
		}
	},
	"@graph": [
		{
			"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2",
			"@type": "InteractionList",
			"hasInteraction": [
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931574",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931574_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"aluminium hydroxide\" outputclass=\"int-drug\">aluminium hydroxide</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   aluminium hydroxide   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "1",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Aluminium hydroxide</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931575",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931575_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"antacids\" outputclass=\"int-drug\">antacids</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   antacids   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "2",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Antacids</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931576",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931576_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium acetate\" outputclass=\"int-drug\">calcium acetate</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium acetate   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "3",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium acetate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931577",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931577_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium carbonate\" outputclass=\"int-drug\">calcium carbonate</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium carbonate   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "4",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium carbonate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931578",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931578_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium chloride\" outputclass=\"int-drug\">calcium chloride</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium chloride   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "5",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium chloride</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931579",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931579_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium gluconate\" outputclass=\"int-drug\">calcium gluconate</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium gluconate   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "6",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium gluconate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931580",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931580_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium lactate\" outputclass=\"int-drug\">calcium lactate</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium lactate   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "7",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium lactate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931581",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931581_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"calcium phosphate\" outputclass=\"int-drug\">calcium phosphate</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   calcium phosphate   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "8",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Calcium phosphate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931582",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931582_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"docusates\" outputclass=\"int-drug\">docusates</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   docusates   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "9",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Docusates</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931583",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931583_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"iron\" outputclass=\"int-drug\">iron</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   iron   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "10",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Iron</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931584",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931584_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"magnesium\" outputclass=\"int-drug\">magnesium</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   magnesium   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "11",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Magnesium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931585",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931585_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"selenium\" outputclass=\"int-drug\">selenium</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   selenium   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "12",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Selenium</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931586",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931586_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"sodium picosulfate\" outputclass=\"int-drug\">sodium picosulfate</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer makes no recommendation</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   sodium picosulfate   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer makes no recommendation .    \n\n"
						}
					],
					"hasOrder": "13",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Sodium picosulfate</title>"
					}
				},
				{
					"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931587",
					"hasMessage": [
						{
							"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2#bnf_i1643857931587_message_0",
							"hasDitaContent": {
								"@type": "rdf:XMLLiteral",
								"@value": "<p otherprops=\"Severe\" outputclass=\"int-message\">\n  <ph outputclass=\"int-route\">Oral</ph> <ph otherprops=\"zinc\" outputclass=\"int-drug\">zinc</ph> <ph outputclass=\"int-effectQualifier\">might</ph> <ph outputclass=\"int-effect\">decrease</ph> <ph outputclass=\"int-parameter\">the concentration of the active metabolite of</ph> <ph outputclass=\"int-route\">oral</ph> <ph otherprops=\"baloxavir marboxil\" outputclass=\"int-heading-drug\">baloxavir marboxil</ph>. <ph outputclass=\"int-action\">Manufacturer advises avoid</ph>.  </p>"
							},
							"hasEvidence": "Theoretical",
							"hasImportance": "Severe",
							"hasOrder": "1",
							"hasTextContent": "Oral   zinc   might   decrease   the concentration of the active metabolite of   oral   baloxavir marboxil .  Manufacturer advises avoid .    \n\n"
						}
					],
					"hasOrder": "14",
					"hasTitle": {
						"@type": "rdf:XMLLiteral",
						"@value": "<title>Zinc</title>"
					}
				}
			],
			"hasSearchLabel": " Baloxavir marboxil  | Interactions",
			"hasSearchLink": {
				"@id": "http://bnf.nice.org.uk/interaction/baloxavir-marboxil-2.html"
			},
			"hasTitle": {
				"@type": "rdf:XMLLiteral",
				"@value": "<title> Baloxavir marboxil </title>"
			},
			"rdfs:label": "baloxavir marboxil"
		}
	]
}